Exploiting nanotechnology to target cancer
Open Access
- 3 April 2007
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 96 (9), 1315-1319
- https://doi.org/10.1038/sj.bjc.6603707
Abstract
Nanotechnology is increasingly finding use in the management of cancer. Nanoscale devices have impacted cancer biology at three levels: early detection using, for example, nanocantilevers or nanoparticles; tumour imaging using radiocontrast nanoparticles or quantum dots; and drug delivery using nanovectors and hybrid nanoparticles. This review addresses some of the major milestones in the integration of nanotechnology and cancer biology, and the future of nanoscale approaches for cancer management.Keywords
This publication has 29 references indexed in Scilit:
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences, 2006
- Multiplexed electrical detection of cancer markers with nanowire sensor arraysNature Biotechnology, 2005
- Quantum Dots as Cellular ProbesAnnual Review of Biomedical Engineering, 2005
- Temporal targeting of tumour cells and neovasculature with a nanoscale delivery systemNature, 2005
- Nanostructures in BiodiagnosticsChemical Reviews, 2005
- Semiconductor quantum dots as contrast agents for whole animal imagingTrends in Biotechnology, 2004
- Quantum dot ligands provide new insights into erbB/HER receptor–mediated signal transductionNature Biotechnology, 2004
- Tumor Regression by Targeted Gene Delivery to the NeovasculatureScience, 2002
- Tumor Therapy with Targeted Atomic NanogeneratorsScience, 2001
- "Dip-Pen" NanolithographyScience, 1999